YOLFTbeta
Tenax Therapeutics Inc

Tenax Therapeutics Inc

TENX · NASDAQ · Healthcare / Biotechnology

1.62USD+0.01 (+0.62%)

Price History

Full chart

Market Stats

Previous Close1.61
Open1.62
Day Range1.54 – 1.64
52-Week Range1.31 – 19.40
Volume897.10K
Market Cap67.74M
P/E (TTM)0.00
Forward P/E0.30
EPS-1.48
Dividend Yield0.00%
Beta0.82
50-Day Avg6.23
200-Day Avg11.44

About

Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Chapel Hill, North Carolina.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Christopher T. Giordano
  • Employees14
  • Headquarters101 Glen Lennox Drive, Chapel Hill, NC, United States, 27517, USA
  • Websitehttps://www.tenaxthera.com

Leadership

  • Mr. Christopher T. GiordanoCEO, President & Director · b. 1975
  • Mr. Thomas A. McGauleyPrincipal Financial Officer & Principal Accounting Officer · b. 1973
  • Dr. Stuart Rich M.D.Chief Medical Officer & Director · b. 1950
  • Mr. Thomas R. Staab II, CPAChief Financial Officer · b. 1968
  • Mr. Doug RandallChief Business Officer
  • Dr. Douglas Hay Ph.D.Executive Vice President of Regulatory Affairs
  • Mr. Timothy G. Healey M.B.A.Chief Commercial Officer · b. 1966
  • Dr. So-Young Kim M.D.Executive Vice President of Clinical Development & Strategy

Financials

Income Statement

Currency: USD1995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue---1111----25.63K-25.63K-24.13K-47.39K322.35K415.03K288.73K288.73K49.29K49.29K0000000000
Growth (%)----0.00%0.00%0.00%----0.00%+5.86%--+580.26%+28.75%-30.43%0.00%-82.93%0.00%-100.00%---------
Cost of Revenue----100.00K-53.99K-71.63K-71.63K-------39.03K530.21K51.25K129.80K129.80K129.80K9.73K18.95K13.62K9.02K107.28K114.75K108.98K113.33K7.57K--
Gross Profit---100.00K53.99K71.63K71.63K----25.63K-25.63K-24.13K-8.35K-207.86K363.78K158.93K158.93K49.29K39.56K-18.95K-13.62K-9.02K-107.28K-114.75K-108.98K-113.33K-7.57K--
Gross Margin---10000000.00%5399300.00%7162800.00%7162800.00%---100.00%100.00%100.00%-17.63%-64.48%87.65%55.04%55.04%100.00%80.26%----------
Operating Expense---1.00M965.59K2.07M2.07M---2.45M2.45M1.75M-10.21M10.35M8.58M17.03M16.77M13.74M15.68M52.63M9.19M6.88M8.45M9.75M32.62M10.94M8.23M--
Operating Income-2.35M-2.34M-1.90M-900.00K-911.60K-2.00M-2.00M-3.60M-2.27M-2.27M-2.48M-2.48M-1.77M-2.93M-10.20M-10.56M-8.22M-16.87M-16.61M-13.69M-15.64M-52.65M-9.21M-6.89M-8.56M-9.87M-32.73M-11.05M-8.23M-19.49M-56.38M
Operating Margin----90000000.00%-91159700.00%-200219000.00%-200219000.00%---9669.53%9669.53%7344.95%--21528.50%-3276.78%-1980.61%-5844.34%-5753.25%-27775.19%-31729.59%----------
EBITDA-2.26M-2.25M-1.81M-800.00K-857.61K-1.93M-2.26M-3.62M-2.11M-2.54M-2.24M-1.52M-3.01M-8.34M-10.24M-9.95M-8.09M-17.17M-16.46M-13.88M-15.59M-51.87M-9.19M-6.88M-8.55M-9.74M-32.36M-10.93M-7.68M-17.58M-52.60M
EBITDA Margin----80000000.00%-85760500.00%-193056300.00%-226158200.00%---8744.13%5914.59%12460.36%--21613.44%-3086.59%-1950.12%-5947.96%-5701.13%-28171.46%-31634.56%----------
Net Income-2.35M-2.35M-1.91M-800.00K-911.34K-1.67M-1.67M-3.49M-2.23M-2.25M-2.67M-3.33M-3.33M-6.72M-10.51M-10.45M-15.71M-19.54M-19.54M-14.08M-14.08M-43.92M-8.84M-6.81M-8.39M-9.85M-32.47M-11.05M-7.71M-17.60M-52.60M
Net Income Margin----80000000.00%-91133900.00%-167224200.00%-167224200.00%---10427.18%12994.46%13803.28%--22174.01%-3241.30%-3785.81%-6768.30%-6768.30%-28571.63%-28571.63%----------
R&D924.09K924.09K460.98K200.00K224.02K224.02K782.34K1.31M1.43M1.28M1.28M1.20M752.61K940.00K2.97M2.68M2.46M3.00M3.00M6.66M6.66M35.14M3.53M1.24M3.47M4.56M25.15M5.38M3.23M12.71M32.67M
R&D as % of Total Revenue---20000000.00%22402300.00%22402300.00%78233900.00%----4982.35%-4699.32%-3118.87%-6277.61%831.93%593.36%1037.91%1037.91%13513.75%13513.75%----------
Interest Expense-00015.88K1.07K1.07K13.60K0001.66M1.68M3.61M155.00K171.56K7.41M2.21M049.08K49.08K32.50M0001.63K9494.44K23.97K23.00K0
Interest Expense % of Total Revenue---0.00%1588200.00%107000.00%107000.00%---0.00%-6459.93%-6955.73%-327.10%53.22%1785.89%766.22%0.00%99.58%99.58%----------

Balance Sheet

Currency: USD1995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets393.94K393.94K318.16K985.91K500.00K6.20M3.79M1.32M1.49M1.81M1.26M610.79K2.00M8.39M5.03M3.53M5.89M33.94M93.43M93.43M72.99M23.34M9.89M13.34M6.37M6.87M5.99M3.40M11.68M96.69M104.23M
Total Liabilities991.54K991.54K600.67K634.36K600.00K345.44K398.09K81.55K333.75K361.51K313.94K424.57K2.46M1.79M1.20M1.40M6.76M3.64M10.54M10.54M12.56M6.20M1.01M1.57M2.59M2.24M1.75M1.91M3.59M4.69M7.16M
Total Equity-597.60K-597.60K-282.51K351.55K-100.00K5.85M3.39M1.24M1.15M1.45M948.40K186.22K-458.25K6.60M3.83M2.13M-871.46K30.30M82.89M82.89M60.42M17.14M8.88M11.77M3.77M4.63M4.24M1.49M8.10M91.99M97.07M
Cash76.31K76.31K53.86K740.22K200.00K5.47M2.91M524.43K722.54K1.05M588.76K382940.24K4.15M2.88M632.71K3.28M6.34M58.32M58.32M3.66M10.00M1.60M12.37M4.91M6.25M5.58M2.12M9.79M94.85M97.56M
Total Debt281.00K281.00K92.55K177.99K100.00K44.53K177.98K105.57K--191.09K191.09K115.36K1.65M78.19K59.16K1.06M368.77K346.89K346.89K100.16K---171.73K305.04K290.78K807.89K500.90K--
Net Debt204.68K204.68K38.70K-562.22K-100.00K-5.42M-2.73M-524.43K-722.54K-1.05M-588.76K190.71K-824.88K-2.49M-2.80M-573.54K-2.22M-5.97M-57.97M-57.97M-3.56M-10.00M-1.60M-12.37M-4.73M-5.95M-5.29M-1.32M-9.29M-94.85M-97.56M

Cash Flow

Currency: USD1995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.53M-1.53M-872.15K-575.69K-800.00K-913.30K-1.54M-1.90M-2.09M-1.77M-1.99M-2.15M-1.14M-2.28M-4.06M-8.59M-8.40M-4.92M-9.26M-9.26M-9.75M-15.87M-12.14M-5.50M-7.56M-9.27M-10.86M-12.01M-5.90M-14.81M-35.80M
Investing Cash Flow--54.11K-42.14K-50.40K-100.00K-52.04K-317.46K-376.50K-64.61K-104.90K-106.92K-56.18K-19.28K-102.10K-367.33K-541.72K-463.94K-147.99K-147.04K-40.93M-40.93M22.21M3.75M7.35M-1.65K20.11K452.61K-2.32K3.00K--
Financing Cash Flow892.82K892.82K891.83K1.31M400.00K6.24M639.58K465.49K-105.20K2.00M2.39M1.62M1.17M7.24M2.10M7.21M9.19M3.97M66.95M66.95M280.59K280.59K498.49K8.91M96.50K10.60M9.74M8.55M13.57M99.87M38.51M
Capital Expenditure33.70K33.70K2.13K76217.66K17.66K240.25K376.50K37.87K80.42K69.67K21.79K83.95K102.10K99.69K541.72K463.94K152.05K147.04K147.04K109.66K2.88K4.54K7.59K3.57K3.49K5.25K2.33K2.84K00
Free Cash Flow-1.56M-1.56M-874.27K-576.45K-800.00K-930.97K-1.78M-2.27M-2.13M-1.85M-2.06M-2.17M-1.22M-2.38M-4.16M-9.13M-8.87M-5.07M-9.41M-9.41M-9.86M-15.87M-12.15M-5.51M-7.56M-9.28M-10.86M-12.02M-5.90M-14.81M-35.80M
Dividends Paid----------------0000-007.33M-------
FCF to OCF102.20%102.20%100.24%100.13%100.00%101.93%115.62%119.84%101.81%104.53%103.50%101.01%107.38%104.49%102.46%106.31%105.52%103.09%101.59%101.59%101.12%100.02%100.04%100.14%100.05%100.04%100.05%100.02%100.00%100.00%100.00%
Dividend Paid to FCF----------------0.00%0.00%0.00%0.00%-0.00%0.00%-133.11%-------

Earnings

Report DateJul 31, 2000Oct 31, 2000Jan 31, 2001Apr 30, 2001Jul 31, 2001Oct 31, 2001Jan 31, 2002Apr 30, 2002Jul 31, 2002Oct 31, 2002Jan 31, 2003Apr 30, 2003Jul 31, 2003Oct 31, 2003Jan 31, 2004Apr 30, 2004Jul 31, 2004Oct 31, 2004Jan 31, 2005Apr 30, 2005Jul 31, 2005Oct 31, 2005Jan 31, 2006Apr 30, 2006Jul 31, 2006Oct 31, 2006Jan 31, 2007Apr 30, 2007Jul 31, 2007Oct 31, 2007Jan 31, 2008Apr 30, 2008Jul 31, 2008Oct 31, 2008Jan 31, 2009Apr 30, 2009Jul 31, 2009Dec 11, 2009Mar 19, 2010Apr 30, 2010Sep 9, 2010Dec 9, 2010Mar 21, 2011Apr 30, 2011Jul 14, 2011Dec 15, 2011Mar 15, 2012Apr 30, 2012Jul 31, 2012Oct 31, 2012Jan 31, 2013Apr 30, 2013Dec 9, 2013Mar 17, 2014Apr 2, 2014Jul 29, 2014Dec 15, 2014Mar 17, 2015Jul 14, 2015Dec 10, 2015Mar 14, 2016May 10, 2016Aug 9, 2016Nov 9, 2016Mar 16, 2017May 10, 2017Aug 9, 2017Nov 9, 2017Mar 20, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Mar 31, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Mar 30, 2020May 15, 2020Aug 14, 2020Nov 16, 2020Mar 31, 2021May 17, 2021Aug 17, 2021Nov 15, 2021Mar 31, 2022May 16, 2022Aug 11, 2022Nov 10, 2022Mar 31, 2023May 15, 2023Aug 14, 2023Nov 13, 2023Mar 28, 2024May 14, 2024Aug 13, 2024Nov 13, 2024Mar 26, 2025May 14, 2025Aug 13, 2025Nov 12, 2025Mar 10, 2026May 12, 2026Jul 31, 2026Nov 11, 2026
EPS Estimate--------------------------------------4.00-48.00--48.00-52.00-64000.00--64000.00-64000.00-76800.00------0.08-5760.00--12160.00-5600.00-5013.33-4320.00-54.000.00-4160.00-5600.00-5120.00-58.00-3200.00-2880.00-2240.00-1.60-1712.00-1600.00-2336.00-6.20-544.00-576.00-496.00-12.10-304.00-320.00-256.00-288.00-4.20-256.00-208.00-3.20-144.00-144.00-176.00-2.28-29.60-5.60-7.20-8.14-3.06-2.25-1.37-0.42-0.41-0.45-1.12-0.41-0.40-0.38-0.35
EPS Actual-29729.22-56294.47-44575.77-54333.95-58336.49-57184.41-52662.97-213806.12-43373.00-111302.83-50299.47-36273.40-48862.69-49383.76-79293.74-47977.52-39934.07-49969.22-70545.73-57428.40-46539.81-123699.98-70545.73-67076.63-49849.87-48435.04-61673.21-38400.00-70377.68-63668.69-157808.48-192000.07-270464.11-238913.70-493241.31-816000.06-93441.82-52.00-52.00-90909.40-52.00-36.00-70400.00-78123.87-70400.00-76800.00-166400.00-50142.10-137713.81-83975.00-88869.58-54625.34-67.14-13760.00-13978.84-4800.00-4480.00-3200.00-5760.00-52.000.36-6080.00-5440.00-4800.0052.00-3840.00-3520.00-1280.00-0.94-1328.00-2064.00-1680.00-0.91-528.00-448.00-528.00-8.20-608.00-368.00-288.00-960.00-32.80-160.00-240.00-0.80-176.00-176.00-176.00-1.73-12.00-4.00-6.40-12.98-3.12-1.83-0.19-0.18-0.28-0.27-0.40-0.38-0.35-0.35-
Surprise--------------------------------------1200.00%-8.33%--8.33%30.77%-10.00%--10.00%-20.00%-116.67%------83827.13%-138.89%-60.53%20.00%36.17%-33.33%3.70%--46.15%2.86%6.25%189.66%-20.00%-22.22%42.86%40.94%22.43%-29.00%28.08%85.32%2.94%22.22%-6.45%32.23%-100.00%-15.00%-12.50%-233.33%-680.95%37.50%-15.38%75.00%-22.22%-22.22%0.00%24.12%59.46%28.57%11.11%-59.46%-1.96%18.67%86.13%57.65%31.71%40.00%64.29%8.43%12.50%7.89%-
Timing------------------------------------------After-hours-After-hoursAfter-hoursAfter-hours------Pre-market-Pre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hours-Pre-marketPre-market-

Key Statistics & Ratios

Market Cap67.74M
Enterprise Value-46.31M
Trailing P/E0.00
Forward P/E0.30
PEG Ratio1.44
Price / Sales414.72
Price / Book0.63
EPS-1.48
Book Value2.19
Revenue (TTM)0
Gross Profit (TTM)0
EBITDA-19.49M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-59.80%
Return on Assets-37.70%
Shares Outstanding37.42M
Shares Float30.78M
Beta0.82
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 4 analystsTarget 12.56
  • Strong Buy
    3
  • Buy
    1

Ownership Breakdown

Institutions
110.81%
Insiders
0.15%
Retail / Other
0.00%

Top Institutional Holders

  • T. Rowe Price Associates, Inc.
    2.95M7.89%
  • Vivo Capital, LLC
    2.50M6.68%
  • HHG PLC
    1.82M4.85%
  • Perceptive Advisors LLC
    1.70M4.54%
  • VR Adviser, LLC
    1.68M4.48%
  • Ikarian Capital, LLC
    1.02M2.72%
  • Stonepine Capital Management Llc
    975.20K2.61%
  • Millennium Management LLC
    876.23K2.34%
  • Citadel Advisors Llc
    728.56K1.95%
  • Morgan Stanley - Brokerage Accounts
    596.56K1.59%
  • Velan Capital Investment Management LP
    549.99K1.47%
  • Adage Capital Partners Gp LLC
    540.13K1.44%
  • Point72 Asset Management, L.P.
    533.97K1.43%
  • Armistice Capital, LLC
    478.83K1.28%

Top Fund Holders

  • Fidelity Select Biotechnology
    969.20K2.59%
  • Vanguard MStar Total Stk Mkt Idx Invest
    852.26K2.28%
  • iShares Russell 2000 ETF
    644.71K1.72%
  • Strategic Advisers Fidelity US TtlStk
    515.19K1.38%
  • T. Rowe Price Health Sciences
    445.98K1.19%
  • Fidelity Advisor Biotechnology I
    445.10K1.19%

Stock Splits

  • Jan 3, 20241:80
  • Jan 5, 20231:20
  • Feb 26, 20181:20
  • May 13, 20131:20
  • Nov 9, 20091:15